Imbruvica, Janssen
Jeff Sharman, MD, on Improving Response Rates in High-Risk CLL Patients
At the 2017 annual meeting of ASCO, Dr. Jeff Sharman, presented the findings of his study which suggests that ...
JUNE 6, 2017

Load more